Category health

Hyderabad, Apr 08:  Vaginal wall prolapse, a condition commonly seen in postmenopausal women due to weakening of pelvic floor muscles, is often silently endured by many who consider it a normal part of ageing. However, timely and appropriate treatment can offer complete relief, says Dr. Bindu Priya, senior Consultant Urogynecologist at KIMS Cuddles, Secunderabad.

The hospital recently treated a complex case of recurrent vaginal vault prolapse in a 65-year-old woman, who had previously undergone multiple surgeries without lasting success. The patient had a history of hysterectomy performed for uterine fibroids. A few years later, she began experiencing a bulge in the vaginal area, significantly affecting her daily life.

In 2023, she underwent laparoscopic sling surgery, followed by an abdominal mesh repair (sacrocolpopexy) in 2024. Despite these interventions, the prolapse recurred within four months. Upon consulting the Urogynecology specialists at KIMS Cuddles, the case was thoroughly evaluated, and a conservative approach using a vaginal pessary was initially advised, which the patient followed for nearly a year.

As she later opted for a permanent solution, the medical team performed a vaginal reconstructive surgery utilising patients own tissue supports. The procedure included anterior vaginal wall repair, uterosacral ligament suspension to provide strong support, and high perineorrhaphy.

Following the surgery, the patient showed significant improvement and recovered well, with marked relief from symptoms.

Speaking on the occasion, Dr. Bindu Priya emphasized the importance of individualized treatment planning. “Each case of prolapse is unique. Factors such as severity of the condition, previous surgeries, and associated health issues must be carefully considered before deciding the line of treatment,” she said.

She further noted that conditions like pelvic organ prolapse and urinary incontinence, though common with advancing age, are not something women need to suffer in silence. “Early medical consultation can greatly improve quality of life. Social stigma and misconceptions often delay treatment, which should be avoided,” she added.

Dr. Bindu Priya and team Dr. Sai Snehitha also stressed that creating awareness and encouraging women to speak openly about their health concerns is a collective social responsibility.

Apr 8: For decades, seeking world-class medical care in India often meant traveling to New Delhi — a journey that was not just expensive, but emotionally and physically draining for millions of families. Today, that reality is steadily changing.

Across the country, from smaller cities to remote regions, quality healthcare is becoming more accessible than ever before. What was once concentrated in a few urban hubs is now spreading into a more connected, nationwide system — bringing hope closer to people’s homes.

At the heart of this transformation are the people who make healthcare possible: doctors.

Over the past decade, India has made a significant push to strengthen its medical workforce. The number of MBBS seats has more than doubled — rising from about 50,000 in 2014 to nearly 1.2 lakh today. Postgraduate seats have also seen a sharp increase, growing from around 30,000 to about 80,000.

Behind these numbers lies a larger story — one of opportunity and preparedness. With more medical colleges opening and more students entering the profession, India is building a stronger pipeline of trained healthcare professionals. This means that patients in smaller towns no longer have to depend solely on distant metro cities for specialized care.

For families, this shift is deeply personal. It means fewer long journeys in times of crisis, quicker access to treatment, and the comfort of being cared for closer to home.

India’s healthcare journey is far from complete, but the direction is clear: a future where quality medical care is not defined by geography, but guaranteed as a right — wherever you live.

Mumbai, Apr 07: On the occasion of World Health Day, PharmEasy, one of India’s leading healthcare platforms, has launched its latest digital campaign highlighting the growing risk of heart disease among younger Indians and encouraging a shift from reactive treatment to preventive health checkups. The campaign features health educator and advocate Prashant Desai and highlights the importance of early detection and regular screening of heart health. 

In the campaign film, Prashant Desai shares his personal experience, having lost his father at the age of 37, as well as his brother and close friend to heart disease. Drawing from his experience, he highlights how conditions such as diabetes, obesity, hypertension, and sedentary lifestyles significantly increase the risk of heart attacks.  He also emphasises that heart disease often develops over decades, making regular monitoring critical. As part of his routine, he undergoes a comprehensive heart check-up every six months and also ensures his 23-year-old daughter gets tested annually.

To encourage timely screening, PharmEasy is offering a range of heart health checkups, including a Complete Heart Health Check-up with and without ECG. Both packages include a FREE cardiologist consultation for a limited period, helping users take informed next steps.

People often overlook cardiac risk markers, which can indicate the risk of a heart attack more precisely than standard lipid levels. These tests assess 90+ key parameters such as cardiac risk markers, homocysteine, lipid profile, diabetes indicators, liver and kidney function, thyroid levels, vitamin B12, and CBC, among others.

They are recommended for individuals above 30 or earlier, if they have a family history of heart disease or lifestyle-related risk factors like high stress, obesity, or low physical activity. As part of the World Health Day initiative, users can explore these options and book tests directly on the PharmEasy app. https://pharmeasy.sng.link/Ehz6r/4xx4/zxzpThe offering also includes an at-home ECG service: a simple, non-invasive way to monitor heart rhythm without visiting a hospital. Conducted using an FDA-approved 12-lead ECG device by trained professionals, the test ensures accurate, hospital-grade results in the comfort of one’s home. To ensure comfort and privacy, female patients are attended by female technicians.

Commenting on the World Health Day campaign by PharmEasy, Gaurav Verma, Chief Business Officer, PharmEasy (API Holdings), shared: 

“Heart-related conditions are increasingly being reported among younger individuals, often without clear warning signs. Through this initiative, we want to encourage people to make preventive heart health checkups a part of their routine, enabling early detection and timely intervention. With services such as at-home ECG and FREE cardiologist consultation, we are working towards making preventive care more accessible.”

Here’s what Prashant Desai had to say about the campaign: 

“One in four Indians die of heart attack or stroke. Women are 10x more likely to die from heart attack than breast cancer. It is both ubiquitous and inevitable. Even though it starts in childhood, it takes decades to manifest. The difference between dying ‘from it’ or ‘with it’ comes down to specific heart check-up and a regular ECG. I am honored to partner with PharmEasy this World Health Day to bring the best heart-health check-up package to every Indian. Get it done. Your heart and your family will thank you.”

Through this initiative, PharmEasy aims to drive greater awareness around preventive heart health and encourage more individuals to adopt regular screening as part of their overall wellness routine.

Biohub today added 11 new researchers from Columbia University, The Rockefeller University, and Yale University to its Immune Cell Reprogramming program, which aims to harness and bioengineer immune cells for the early detection, prevention, and treatment of a broad spectrum of age-related diseases.

“We are at an extraordinary inflection point, where the convergence of AI, synthetic biology, and immunology is making it possible to move from observing the immune system to truly engineering it,” said Andrea Califano, president of Immune Cell Reprogramming, and head of Biohub New York. “Each of these investigators brings a distinct and essential perspective to that challenge, and together they will help us build the predictive and programmable tools we need to detect and prevent disease long before it takes hold.”

Diseases are often diagnosed only after obvious symptoms appear, while early signals that precede these symptoms are generally missed. Immune cells are well-suited to fill this gap, as they constantly monitor and maintain the health of organs and tissues while circulating through the blood and lymphatic systems. By deciphering the molecular language these cells use to report problems they’ve identified, researchers can leverage and augment their ability to spot and even treat hard-to-detect cancers and other diseases that can evade the immune response. Better understanding and measurement of how immune cells monitor abnormalities also opens avenues to program new functions into these cells, allowing them to take therapeutic actions, such as repairing damaged cells or eliminating diseased ones.

Through its Investigator Program and parallel Affiliated Investigator cohort, Biohub accelerates research led by scientists, engineers, and technologists by providing them with unrestricted funding to pursue their most innovative and high-impact research projects. The new Investigators will join a vibrant, collaborative, and supportive research community in New York, gaining access to cutting-edge tools, expertise, and training opportunities.

All India Institute of Medical Sciences Delhi has introduced a state-of-the-art virtual reality (VR) training centre aimed at enhancing medical education and clinical training for students.

The new facility uses immersive VR technology to simulate real-life medical scenarios, allowing students to practice procedures and decision-making in a controlled, risk-free environment. This approach is expected to strengthen practical skills and improve confidence before handling actual patients.

According to institute officials, the initiative is part of a broader effort to integrate advanced technology into medical training and keep pace with global standards in healthcare education. The VR centre will support learning across multiple disciplines, offering interactive modules tailored to various medical specialties.

The launch marks a significant step toward modernizing medical education in India, providing students with innovative tools to gain hands-on experience and improve patient care outcomes.

Chennai, Apr 06: Shri M. Venkaiah Naidu, former Vice President of India, is set to inaugurate the 10th edition of CAHOCON 2026, India’s premier healthcare quality conference organized by the Consortium of Accredited Healthcare Organizations (CAHO), scheduled to be held in Chennai from April 10 to 12, 2026.

Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals Group, will be the Guest of Honour at the inaugural session. Dr. C. Sylendra Babu, IPS (Retd.), former Director General of Police and Head of Police Force, Tamil Nadu, will be the Guest of Honour at the Graduation Ceremony. The event is expected to bring together around 2,500 healthcare leaders, clinicians, administrators, and policymakers, including over 200 international delegates, to deliberate on advancements in patient safety, healthcare quality, accreditation, and digital transformation. Ms. Mallika Srinivasan, Chairman & MD, TAFE will be the Chief Guest and Mr. Sunil Kumar Barnwal IAS, Additional Secretary and CEO, National Health Authority, Government of India will be the Guest of Honour at the valedictory ceremony.

Other dignitaries participating in CAHOCON 2026 include Dr. Vijay Agarwal, President; Dr. Lallu Joseph, Secretary General, Consortium of Accredited Healthcare Organizations, and AGS & Quality Manager at Christian Medical College Vellore; Dr. Nalla G Palaniswami, Organizing Chairperson CAHOCON 2026, and Chairman of Kovai Medical Centre and Hospital; Dr. S. Manivannan, Organizing Co-Chairperson, and Founder & Managing Director of Kauvery Group of Hospitals; Dr. Sathish Devadoss, Organizing Secretary, and Vice Chairman of Devadoss Multispecialty Hospitals; and Dr. Ilankumaran Kaliamoorthy, Academic Committee Member, CAHOCON 2026, and CEO of Apollo Hospitals Chennai.

Guided by the theme ‘Tech, Touch, Trust- The new Healthcare code.’, CAHOCON 2026 will emphasize the human connection, reliability, and innovation at the heart of advancing healthcare quality and patient safety. The main conference will feature high-impact scientific sessions, panel discussions, innovation showcases, and interactive networking opportunities, along with poster presentations by researchers and clinicians that highlight innovative projects and foster knowledge exchange.

Alongside the conference, CAHOCON 2026 will host a comprehensive healthcare exhibition with over 200 stalls, showcasing cutting-edge products and services from leading medical equipment manufacturers, digital health companies, pharmaceutical firms, and service providers. The conference will also feature four breakout houses, designed to facilitate smaller group discussions, interactive workshops, and focused learning sessions.

Recognized by the International Society for Quality in Health Care (ISQua) as the first ISQua Regional Conference for South Asia, CAHOCON 2026 will witness addresses by 20 ISQua experts. The conference will honour excellence in healthcare quality and patient safety through the prestigious CAHO Awards, celebrating institutions and professionals who have made outstanding contributions to advancing healthcare standards.

A key highlight of CAHOCON 2026 is the pre-conference workshops. Over 40 such workshops will be organized on April 10 engaging 32 leading hospitals from Chennai, providing hands-on training and practical insights into quality improvement and patient safety for the participants.

Over the past decade, CAHO has evolved into a powerful national movement dedicated to strengthening healthcare quality and patient safety across India. Through continuous training, accreditation support, knowledge-sharing platforms and collaborative initiatives, the organization is working to build a culture where quality and safety are embedded in every aspect of healthcare delivery.

CAHOCON is one of the most influential platforms for advancing healthcare quality and patient safety in India. This collaborative forum aims to strengthen a culture of continuous improvement in healthcare systems and ensure that patients across the country benefit from safer and higher-quality care.

New Delhi: The Jan Vishwas Bill is expected to bring significant relief to India’s healthcare ecosystem by reducing regulatory pressure and encouraging smoother operations across the sector, according to the Ministry.

The Bill focuses on decriminalising minor offences and replacing them with civil penalties, a move that could greatly benefit hospitals, diagnostic centres, pharmaceutical firms, and medical device companies. Instead of facing criminal action for procedural lapses, healthcare providers will now be subject to warnings, improvement notices, or monetary penalties—making compliance less intimidating and more practical.

Pic Credit: Pexel

For the health sector, this shift is particularly important. Medical institutions often deal with complex regulations, and even small documentation errors could earlier lead to severe legal consequences. By removing the fear of criminal prosecution for such minor issues, the Bill allows healthcare professionals to focus more on patient care rather than legal risks.

The reform is also expected to boost investment and innovation. A more predictable and business-friendly regulatory environment can attract new players in areas like pharmaceuticals, medical technology, and health services. This could improve infrastructure, expand access to care, and support the growth of India’s healthcare industry.

Additionally, faster and more transparent compliance processes may improve service delivery. With fewer legal hurdles, approvals and operations can become more efficient, ultimately benefiting patients through better access and reduced delays.

Officials believe that the Bill will not only enhance ease of doing business but also strengthen the overall healthcare system by making it more responsive, efficient, and growth-oriented.

LOS ANGELES, Apr 4: Investigators at Cedars-Sinai Health Sciences University have unveiled a series of groundbreaking studies spanning cardiac arrest prevention, cancer therapeutics, hypertension, gastrointestinal research, and advanced molecular analysis—highlighting the institution’s continued leadership in innovation-driven healthcare.

AI-Powered Algorithm Could Improve Access to Lifesaving AEDs

Researchers have developed a novel algorithm designed to optimize the placement of automated external defibrillators (AEDs), portable devices critical in treating sudden cardiac arrest. By analyzing incident data across Ventura County, California, and Multnomah County, Oregon (2012–2023), the algorithm identifies clusters of cardiac arrest cases and recommends AED placement within close proximity.

“Faster access to AEDs can significantly improve survival outcomes,” said Sumeet Chugh, senior author of the study. “This tool could help communities strategically position these lifesaving devices where they are needed most.”

The findings were published in IJC Heart & Vasculature, with further studies planned to validate the algorithm’s effectiveness in real-world settings.

Pharmacist-Led Care Reduces Readmissions in High-Risk Older Adults

A large multisite clinical trial involving over 6,000 patients found that older adults struggling with medication adherence were 10% less likely to be readmitted to the hospital when supported by pharmacist-led discharge care.

“This targeted intervention shows promise for patients who need it most,” said Joshua Pevnick, corresponding author of the study. “Improving medication understanding can meaningfully impact recovery outcomes.”

The study, published in JAMA Network Open, underscores the importance of personalized care strategies in improving post-discharge health.

New Drug Candidate Targets Key Proteins in Colon and Liver Cancer

Cedars-Sinai scientists have identified a promising compound that disrupts the interaction between two proteins—GIT1 and MAT2B—known to drive colorectal and liver cancer growth. The compound, known as C3, slows tumor progression and promotes cancer cell death in preclinical models.

“We’re excited about the potential of this dual-target approach,” said Shelly Lu, corresponding author. “This discovery could pave the way for more effective therapies across multiple cancer types.”

The study appears in Cell Death & Disease, with ongoing work focused on refining the compound for clinical application.

First-Ever Model of Functional Paneth Cells Created

In a major advancement for gastrointestinal research, Cedars-Sinai investigators have successfully developed human intestinal organoids containing functional Paneth cells—an achievement not previously accomplished.

“This model opens new pathways for studying diseases like Crohn’s,” said Robert Barrett, lead researcher. “It also holds promise for personalized medicine approaches using patient-derived cells.”

Published in Cellular and Molecular Gastroenterology and Hepatology, the study could accelerate research into immune-related gut disorders.

Genetic Insights Offer New Hope for Resistant Hypertension

A large-scale genetic study analyzing data from over 92,000 individuals has identified key variants linked to resistant hypertension—a condition affecting more than 10% of patients with high blood pressure.

“Pinpointing these genetic drivers allows for better diagnosis and targeted treatments,” said Joseph Ebinger. “This could ultimately reduce the risk of severe cardiovascular events.”

The findings, published in Hypertension, highlight the role of hormonal imbalance, particularly excess aldosterone, in difficult-to-control blood pressure.

Rapid ‘Multi-Omics’ Technique Could Transform Biomedical Research

Researchers have also introduced a cutting-edge analytical method—Single-Injection Multi-Omics Analysis by Direct Infusion (SMAD)—capable of identifying thousands of proteins and molecular features from a single sample in under five minutes.

“This technology can significantly accelerate drug discovery and biological research,” said Jesse Meyer, senior author of the study.

Detailed in Angewandte Chemie, the approach offers a faster, more cost-effective alternative to traditional molecular analysis workflows.

Driving the Future of Medicine

Collectively, these studies demonstrate Cedars-Sinai’s commitment to advancing precision medicine, improving patient outcomes, and accelerating the translation of research into real-world healthcare solutions.

From AI-powered tools and genetic insights to novel therapies and analytical technologies, Cedars-Sinai continues to shape the future of medicine through innovation and collaboration.

SAN FRANCISCO, CA – Apr 1 – Canopy, the category leader in connected safety platforms for U.S. health systems, announced that it now protects more than 350,000 lives nationwide and has expanded itsClinical Strategy Team to further the shift from reactive incident response to proactive, pre-escalation prevention with rich clinical focus and experience.

As workplace violence, nurse burnout, and staff turnover continue to strain hospital margins, Canopy is investing in deep clinical expertise to provide health systems with the strategies and tools needed for safer daily operations. The expansion includes the addition of Dr. Ryan Oglesby, PhD, MHA, RN, CEN, CFRN, NEA-BC, 2025 National Emergency Nurses Association (ENA) and this year’s Past President, as a Clinical Strategy Director. He joins current Clinical Strategy Director Jeanne Venella, DNP, MS, CEN, CPEN, a nationally recognized expert in clinical operations and patient safety. Together, they strengthen Canopy’s ability to partner directly with executive and nurse leaders on large-scale safety initiatives.

“At Canopy, we’re turning the commitment to nurse safety into real-world, real-time activation so that bedside caregivers can get help the moment they need it,” said Ryan Oglesby, Clinical Strategy Director. “By growing this clinical strategy team, we are bridging the gap between frontline caregivers and hospital leadership to ensure the protections necessary to keep clinicians focused on taking care of patients.”

The company’s rapid growth, fueled by its expanding team and recent Series B funding, reflects rising demand from health system leaders who recognize that safety is a critical driver of patient outcomes. Workplace violence drives turnover, increases labor costs, and disrupts productivity. To address these challenges, Canopy is accelerating the evolution of its Connected Safety Platform.

Over the past six months, Canopy has introduced enhanced mobile responder capabilities across Android and iOS, as well as integrations with Epic, Vocera, and TigerConnect, providing security and clinical teams with immediate, high-fidelity location data. Coupled with advanced reporting and real-time analytics, these updates empower leadership to identify high-risk areas and optimize response protocols.

In their recent Healthcare Safety Report, which surveyed over 1,000 healthcare workers and leaders, Canopy found that nearly 85% of respondents have experienced at least one workplace violence event in their careers. The report also highlighted a direct link to turnover, with over one-third of workers considering leaving their positions due to safety issues.

“Our mission is to safeguard healthcare workers wherever they occur across the campus—from the parking garage to the exam room,” said Jeanne Venella, Clinical Strategy Director. “As hospitals move beyond simply reacting to incidents, we are providing the infrastructure for a prevention-first model that strengthens both staff well-being and overall operations.” At the last ENA conference I attended, a nurse approached me in our exhibit hall and stated, “My Canopy button saved my life last week!” Emergency Department Nurse at TJU.

Canopy’s platform is actively trusted by leading organizations, including the University of Michigan Health-Sparrow and ECU Health. The company will continue expanding its Clinical Strategy Team as part of its long-term commitment to helping health systems protect their people and performance.

“We knew we couldn’t eliminate workplace violence entirely, but we could certainly prevent the harm coming to our team members. We wanted them to feel empowered, not monitored. Once we rolled [Canopy’s platform] out, you could feel the shift—they finally felt safer.” Chris Nemets, Regional CNIO, University of Michigan Health, states about incorporating Canopy into Michigan Health’s system.

Pic Credit: Pexel

India’s bioeconomy is fast emerging as one of the country’s most dynamic growth engines, steadily approaching the $200 billion mark. Fueled by innovation, research, and a thriving startup ecosystem, the sector is redefining how science contributes to economic progress and everyday life.

From Niche to Mainstream

Once limited to specialized research and pharmaceuticals, the bioeconomy has expanded into a wide spectrum of industries, including healthcare, agriculture, biofuels, and environmental solutions. This transformation reflects India’s ability to combine scientific expertise with real-world applications, creating solutions that are both scalable and impactful.

Innovation Driving the Momentum

At the heart of this growth lies a strong push for innovation. Startups, research institutions, and established companies are working together to develop next-generation technologies in areas such as biotechnology, genomics, and sustainable agriculture.

Supportive government policies and increased funding have further accelerated this momentum, enabling new ideas to move from laboratories to markets more quickly than ever before.

Beyond Growth: A Broader Impact

The rise of the bioeconomy is not just an economic story—it is also about addressing critical challenges. From improving healthcare access to developing climate-resilient crops and clean energy alternatives, the sector is playing a key role in shaping a more sustainable future.

It is also creating skilled jobs, attracting global investments, and strengthening India’s position as a hub for affordable and innovative solutions.

Looking Ahead

As the bioeconomy edges closer to the $200 billion milestone, the focus is shifting toward scaling innovation and deepening collaboration between industry and academia. Strengthening infrastructure and nurturing talent will be crucial to sustaining this growth.

With strong foundations and growing global relevance, India’s bioeconomy is entering a new phase—one defined by innovation, resilience, and the potential to make a lasting impact on both the economy and society.